{"component": "contracts", "props": {"contracts": [{"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of AquaBounty Technologies, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 31st day of October, 2019.", "id": "7dHdHMEKVQc", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036119019471/ex3.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "October 31st, 2019", "published": true, "pretty": null, "uri": "/contracts/7dHdHMEKVQc", "title": "Joint Filing Agreement", "group_id": "7dHdHMEKVQc", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/7dHdHMEKVQc", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Fishing, hunting and trapping", "type": "industry", "uri": "/contracts/tagged/fishing-hunting-and-trapping"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Fibrocell Science, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 10th day of March, 2017.", "id": "7pJtntYBVr1", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117011609/ex99.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "March 10th, 2017", "published": true, "pretty": null, "uri": "/contracts/7pJtntYBVr1", "title": "Joint Filing Agreement", "group_id": "7pJtntYBVr1", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/7pJtntYBVr1", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Soligenix, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 16th day of June, 2017.", "id": "827szVIrMCc", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117025386/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "June 16th, 2017", "published": true, "pretty": null, "uri": "/contracts/827szVIrMCc", "title": "Joint Filing Agreement", "group_id": "827szVIrMCc", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/827szVIrMCc", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "THIS NOMINEE AGREEMENT is entered into as of June 29, 2018, by and between KAPITAL JOE, LLC (\u201cKapital Joe\u201d) and the R.J. KIRK DECLARATION OF TRUST (the \u201cRJ Kirk DOT\u201d).", "id": "82jHdZ5UJ23", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036118031796/ex1.htm", "category_name": "Nominee Agreement", "company_name": "Kirk Randal J", "created": "July 6th, 2018", "published": true, "pretty": null, "uri": "/contracts/82jHdZ5UJ23", "title": "NOMINEE AGREEMENT", "group_id": "82jHdZ5UJ23", "group_samples": [{"label": "Nominee Agreement (Kirk Randal J)", "uri": "/contracts/82jHdZ5UJ23", "published": true}], "group_size": 1, "tags": [{"name": "Nominee Agreement", "type": "category", "uri": "/contracts/tagged/nominee-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Histogenics Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 15th day of January, 2019.", "id": "899eJjUfjoR", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036119001134/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "January 15th, 2019", "published": true, "pretty": null, "uri": "/contracts/899eJjUfjoR", "title": "Joint Filing Agreement", "group_id": "899eJjUfjoR", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/899eJjUfjoR", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Orthopedic, prosthetic & surgical appliances & supplies", "type": "industry", "uri": "/contracts/tagged/orthopedic-prosthetic-surgical-appliances-supplies"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13G (including amendments thereto) with regard to the common stock of AmpliPhi Biosciences Corporation and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 13th day of February, 2015.", "id": "8LtXDe56fg0", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036115006434/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "February 13th, 2015", "published": true, "pretty": null, "uri": "/contracts/8LtXDe56fg0", "title": "Joint Filing Agreement", "group_id": "8LtXDe56fg0", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/8LtXDe56fg0", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Biological products, (no disgnostic substances)", "type": "industry", "uri": "/contracts/tagged/biological-products-no-disgnostic-substances"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Clinical Data, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 14th day of February, 2006.", "id": "8XVmnDmB7Ri", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036106002445/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "February 15th, 2006", "published": true, "pretty": null, "uri": "/contracts/8XVmnDmB7Ri", "title": "JOINT FILING AGREEMENT", "group_id": "8XVmnDmB7Ri", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/8XVmnDmB7Ri", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Synthetic Biologics, Inc. and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 19th day of December, 2013.", "id": "8vwYmNsWdDK", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036113047005/ex_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "December 19th, 2013", "published": true, "pretty": null, "uri": "/contracts/8vwYmNsWdDK", "title": "Joint Filing Agreement", "group_id": "8vwYmNsWdDK", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/8vwYmNsWdDK", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Transgenomic, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 12th day of January, 2016.", "id": "8zUGkaDWihq", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036116047621/ex99_22.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "January 12th, 2016", "published": true, "pretty": null, "uri": "/contracts/8zUGkaDWihq", "title": "Joint Filing Agreement", "group_id": "8zUGkaDWihq", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/8zUGkaDWihq", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Clinical Data, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 22nd day of September, 2009.", "id": "9Fae6wwOEDe", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036109021440/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "September 22nd, 2009", "published": true, "pretty": null, "uri": "/contracts/9Fae6wwOEDe", "title": "JOINT FILING AGREEMENT", "group_id": "9Fae6wwOEDe", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9Fae6wwOEDe", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of ZIOPHARM Oncology, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 11th day of February, 2011.", "id": "9I7GPKuxaNI", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036111008317/ex5.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "February 11th, 2011", "published": true, "pretty": null, "uri": "/contracts/9I7GPKuxaNI", "title": "Joint Filing Agreement", "group_id": "9I7GPKuxaNI", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9I7GPKuxaNI", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-specialty outpatient facilities, nec", "type": "industry", "uri": "/contracts/tagged/services-specialty-outpatient-facilities-nec"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Adeona Pharmaceuticals, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 12th day of December, 2011.", "id": "9R3KbXKzjLW", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036111057083/ex4.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "December 12th, 2011", "published": true, "pretty": null, "uri": "/contracts/9R3KbXKzjLW", "title": "Joint Filing Agreement", "group_id": "9R3KbXKzjLW", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9R3KbXKzjLW", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13G (including amendments thereto) with regard to the common stock of New River Pharmaceuticals Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 14th day of February, 2007.", "id": "9RTctbcaX0F", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036107003398/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "February 14th, 2007", "published": true, "pretty": null, "uri": "/contracts/9RTctbcaX0F", "title": "JOINT FILING AGREEMENT", "group_id": "9RTctbcaX0F", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9RTctbcaX0F", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Soligenix, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 8th day of May, 2017.", "id": "9Xjmhk7vAgk", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117018900/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 8th, 2017", "published": true, "pretty": null, "uri": "/contracts/9Xjmhk7vAgk", "title": "Joint Filing Agreement", "group_id": "9Xjmhk7vAgk", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9Xjmhk7vAgk", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Soligenix, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 26th day of May, 2017.\n", "id": "9cZnUKs8AdF", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117022589/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 26th, 2017", "published": true, "pretty": null, "uri": "/contracts/9cZnUKs8AdF", "title": "Joint Filing Agreement", "group_id": "9cZnUKs8AdF", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9cZnUKs8AdF", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Precipio, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 14th day of September, 2018.", "id": "9hULouzB0NG", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036118038466/ex99_36.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "September 14th, 2018", "published": true, "pretty": null, "uri": "/contracts/9hULouzB0NG", "title": "Joint Filing Agreement", "group_id": "9hULouzB0NG", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/9hULouzB0NG", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "THIS COMMON STOCK PURCHASE WARRANT (the \u201cWarrant\u201d) certifies that, for value received,___________(the \u201cHolder\u201d), is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time six (6) months after the date hereof (the \u201cInitial Exercise Date\u201d) and on or prior to the close of business on the fifth (5th) year anniversary of the Initial Exercise Date (the \u201cTermination Date\u201d) but not thereafter, to subscribe for and purchase from Clinical Data, Inc., a Delaware corporation (the \u201cCompany\u201d), up to [aggregate 50% of Common Stock purchased in offering] shares (the \u201cWarrant Shares\u201d) of Common Stock, par value $0.01 per share, of the Company (the \u201cCommon Stock\u201d). The purchase price of one share of Common Stock under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b).", "id": "9u4nk1WqolF", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036106009209/ex4_1.htm", "category_name": "Security Agreement", "company_name": "Kirk Randal J", "created": "June 15th, 2006", "published": true, "pretty": null, "uri": "/contracts/9u4nk1WqolF", "title": "COMMON STOCK PURCHASE WARRANT To Purchase ____________ Shares of Common Stock of CLINICAL DATA, INC.", "group_id": "9u4nk1WqolF", "group_samples": [{"label": "Security Agreement (Kirk Randal J)", "uri": "/contracts/9u4nk1WqolF", "published": true}], "group_size": 1, "tags": [{"name": "Security Agreement", "type": "category", "uri": "/contracts/tagged/security-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Transgenomic, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 10th day of January, 2011.", "id": "a0LDnIFxPgG", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036111002249/ex5.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "January 11th, 2011", "published": true, "pretty": null, "uri": "/contracts/a0LDnIFxPgG", "title": "Joint Filing Agreement", "group_id": "a0LDnIFxPgG", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/a0LDnIFxPgG", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of AmpliPhi Biosciences Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 30th day of December, 2016.", "id": "a9HAFnggV8L", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036116091205/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "December 30th, 2016", "published": true, "pretty": null, "uri": "/contracts/a9HAFnggV8L", "title": "Joint Filing Agreement", "group_id": "a9HAFnggV8L", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/a9HAFnggV8L", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Biological products, (no disgnostic substances)", "type": "industry", "uri": "/contracts/tagged/biological-products-no-disgnostic-substances"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Fibrocell Science, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 27th day of July, 2015.", "id": "aIrD40y5aPG", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036115028729/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "July 27th, 2015", "published": true, "pretty": null, "uri": "/contracts/aIrD40y5aPG", "title": "Joint Filing Agreement", "group_id": "aIrD40y5aPG", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/aIrD40y5aPG", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of ZIOPHARM Oncology, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 25th day of January, 2012.", "id": "aMfAMrkpBrY", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036112003616/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "January 25th, 2012", "published": true, "pretty": null, "uri": "/contracts/aMfAMrkpBrY", "title": "Joint Filing Agreement", "group_id": "aMfAMrkpBrY", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/aMfAMrkpBrY", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-specialty outpatient facilities, nec", "type": "industry", "uri": "/contracts/tagged/services-specialty-outpatient-facilities-nec"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of AmpliPhi Biosciences Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 20th day of March, 2015.", "id": "aPNVr4tjXwI", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036115012832/ex4.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "March 20th, 2015", "published": true, "pretty": null, "uri": "/contracts/aPNVr4tjXwI", "title": "Joint Filing Agreement", "group_id": "aPNVr4tjXwI", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/aPNVr4tjXwI", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Biological products, (no disgnostic substances)", "type": "industry", "uri": "/contracts/tagged/biological-products-no-disgnostic-substances"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Intrexon Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 15th day of May, 2019.", "id": "b3YlMjkGhBK", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000156761919011319/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 15th, 2019", "published": true, "pretty": null, "uri": "/contracts/b3YlMjkGhBK", "title": "Joint Filing Agreement", "group_id": "b3YlMjkGhBK", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/b3YlMjkGhBK", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Soligenix, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 9th day of May, 2013.", "id": "b7oLqtqGt7M", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036113019813/ex3.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 9th, 2013", "published": true, "pretty": null, "uri": "/contracts/b7oLqtqGt7M", "title": "Joint Filing Agreement", "group_id": "b7oLqtqGt7M", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/b7oLqtqGt7M", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Intrexon Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 24th day of May, 2019.", "id": "bKmVZsUrSDE", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036119009838/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 28th, 2019", "published": true, "pretty": null, "uri": "/contracts/bKmVZsUrSDE", "title": "Joint Filing Agreement", "group_id": "bKmVZsUrSDE", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/bKmVZsUrSDE", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Intrexon Corporation, and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 2nd day of June, 2016.", "id": "bNCLPb4qCvf", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036116068299/ex99_3.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "June 2nd, 2016", "published": true, "pretty": null, "uri": "/contracts/bNCLPb4qCvf", "title": "Joint Filing Agreement", "group_id": "bNCLPb4qCvf", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/bNCLPb4qCvf", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of ZIOPHARM Oncology, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 20th day of January, 2011.", "id": "bXcfVt3eh0B", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036111003560/ex4.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "January 20th, 2011", "published": true, "pretty": null, "uri": "/contracts/bXcfVt3eh0B", "title": "Joint Filing Agreement", "group_id": "bXcfVt3eh0B", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/bXcfVt3eh0B", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-specialty outpatient facilities, nec", "type": "industry", "uri": "/contracts/tagged/services-specialty-outpatient-facilities-nec"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Oragenics, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 22nd day of November, 2013.", "id": "bwXraG9BHD2", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036113043928/ex1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "November 22nd, 2013", "published": true, "pretty": null, "uri": "/contracts/bwXraG9BHD2", "title": "Joint Filing Agreement", "group_id": "bwXraG9BHD2", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/bwXraG9BHD2", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Halozyme Therapeutics, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 16th day of August, 2018.", "id": "c5KzUxx1yS", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036118036549/ex_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "August 16th, 2018", "published": true, "pretty": null, "uri": "/contracts/c5KzUxx1yS", "title": "JOINT FILING AGREEMENT", "group_id": "c5KzUxx1yS", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/c5KzUxx1yS", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Biological products, (no disgnostic substances)", "type": "industry", "uri": "/contracts/tagged/biological-products-no-disgnostic-substances"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Transgenomic, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 11th day of April, 2017.", "id": "cDCmj60QqB", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117015566/ex25.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "April 11th, 2017", "published": true, "pretty": null, "uri": "/contracts/cDCmj60QqB", "title": "Joint Filing Agreement", "group_id": "cDCmj60QqB", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/cDCmj60QqB", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons names below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Clinical Data, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 23rd day of May, 2006.", "id": "cO1n3F5FOAF", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036106007966/ex99_1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "May 23rd, 2006", "published": true, "pretty": null, "uri": "/contracts/cO1n3F5FOAF", "title": "JOINT FILING AGREEMENT", "group_id": "cO1n3F5FOAF", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/cO1n3F5FOAF", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of AquaBounty Technologies, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 24th day of November, 2021.", "id": "cQFJsnKOpkz", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036121039361/brhc10031173_ex99-1.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "November 24th, 2021", "published": true, "pretty": null, "uri": "/contracts/cQFJsnKOpkz", "title": "Joint Filing Agreement", "group_id": "cQFJsnKOpkz", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/cQFJsnKOpkz", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Fishing, hunting and trapping", "type": "industry", "uri": "/contracts/tagged/fishing-hunting-and-trapping"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Transgenomic, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 12th day of June, 2017.", "id": "cWeiWGj44MK", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036117024722/ex99_26.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "June 12th, 2017", "published": true, "pretty": null, "uri": "/contracts/cWeiWGj44MK", "title": "Joint Filing Agreement", "group_id": "cWeiWGj44MK", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/cWeiWGj44MK", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Laboratory analytical instruments", "type": "industry", "uri": "/contracts/tagged/laboratory-analytical-instruments"}]}, {"intro": "THIS SUBSCRIPTION AGREEMENT (this \u201cAgreement\u201d) is made as of December 29, 2017 by and between Intrexon Corporation, a Virginia corporation (the \u201cCompany\u201d), and the investor listed on Schedule A hereto (the \u201cInvestor\u201d).", "id": "cYFzstXHCYX", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036118000009/ex99_1.htm", "category_name": "Subscription Agreement", "company_name": "Kirk Randal J", "created": "January 2nd, 2018", "published": true, "pretty": null, "uri": "/contracts/cYFzstXHCYX", "title": "SUBSCRIPTION AGREEMENT", "group_id": "cYFzstXHCYX", "group_samples": [{"label": "Subscription Agreement (Kirk Randal J)", "uri": "/contracts/cYFzstXHCYX", "published": true}], "group_size": 1, "tags": [{"name": "Subscription Agreement", "type": "category", "uri": "/contracts/tagged/subscription-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Services-commercial physical & biological research", "type": "industry", "uri": "/contracts/tagged/services-commercial-physical-biological-research"}, {"name": "Delaware", "type": "jurisdiction", "uri": "/contracts/tagged/delaware-us"}]}, {"intro": "In accordance with Rule 13d-1(k) promulgated under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing on behalf of each of them a Statement on Schedule 13D (including amendments thereto) with regard to the common stock of Fibrocell Science, Inc., and further agree that this Joint Filing Agreement be included as an exhibit to such joint filings. In evidence thereof, the undersigned, being duly authorized, hereby execute this agreement as of the 17th day of September, 2019.", "id": "cpYUdAt8r62", "source_url": "https://www.sec.gov/Archives/edgar/data/1091823/000114036119016843/ex3.htm", "category_name": "Joint Filing Agreement", "company_name": "Kirk Randal J", "created": "September 17th, 2019", "published": true, "pretty": null, "uri": "/contracts/cpYUdAt8r62", "title": "Joint Filing Agreement", "group_id": "cpYUdAt8r62", "group_samples": [{"label": "Joint Filing Agreement (Kirk Randal J)", "uri": "/contracts/cpYUdAt8r62", "published": true}], "group_size": 1, "tags": [{"name": "Joint Filing Agreement", "type": "category", "uri": "/contracts/tagged/joint-filing-agreement"}, {"name": "Kirk Randal J", "type": "company", "uri": "/company/1091823/kirk-randal-j"}, {"name": "Pharmaceutical preparations", "type": "industry", "uri": "/contracts/tagged/pharmaceutical-preparations"}]}], "next_curs": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLY3BZVWRBdDhyNjIYACAB", "cursor": "CjEKEAoKZ3JvdXBfc2l6ZRICCAEKGQoIZ3JvdXBfaWQSDRoLN0NCZElxaklWQkUYACAB"}}